Solara Active Pharma Sciences
Solara Active Pharma Sciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Solara Active Pharma Sciences
Start SIPSolara Active Pharma Sciences F&O
Solara Active Pharma Sciences Investment Rating
-
Master Rating:
-
Solara Active Pharma Scis has an operating revenue of Rs. 1,424.01 Cr. on a trailing 12-month basis. An annual revenue de-growth of -22% needs improvement, Pre-tax margin of -7% needs improvement, ROE of -3% is poor and needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 26% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 36 which is a POOR score indicating inconsistency in earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 395 | 338 | 330 | 361 |
| Operating Expenses Qtr Cr | 349 | 311 | 320 | 348 |
| Operating Profit Qtr Cr | 45 | 28 | 10 | 13 |
| Depreciation Qtr Cr | 28 | 29 | 28 | 28 |
| Interest Qtr Cr | 24 | 22 | 23 | 21 |
| Tax Qtr Cr | 0 | -9 | -15 | -33 |
| Net Profit Qtr Cr | 0 | -10 | -19 | 0 |
Solara Active Pharma Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 371.22
- 50 Day
- 386.37
- 100 Day
- 406.12
- 200 Day
- 475.8
- 20 Day
- 367.17
- 50 Day
- 388.84
- 100 Day
- 415.5
- 200 Day
- 408.19
Solara Active Pharma Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 366.75 |
| Second Resistance | 372.2 |
| Third Resistance | 376.6 |
| RSI | 43.19 |
| MFI | 73.05 |
| MACD Single Line | -6.75 |
| MACD | -5.33 |
| Support | |
|---|---|
| First Resistance | 356.9 |
| Second Resistance | 352.5 |
| Third Resistance | 347.05 |
Solara Active Pharma Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 40,521 | 1,964,863 | 48.49 |
| Week | 124,890 | 3,315,830 | 26.55 |
| 1 Month | 74,911 | 2,588,931 | 34.56 |
| 6 Month | 100,260 | 3,133,139 | 31.25 |
Solara Active Pharma Sciences Result Highlights
Solara Active Pharma Sciences Synopsis
NSE-Medical-Diversified
Solara Active Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1268.34 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2022. Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636.| Market Cap | 1,314 |
| Sales | 1,424 |
| Shares in Float | 2.16 |
| No of funds | 48 |
| Yield |
| Book Value | 0.86 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | 19 |
| Alpha | -0.21 |
| Beta | 1.06 |
Solara Active Pharma Sciences
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 40.4% | 40.4% | 40.4% | |
| Mutual Funds | 2.51% | 2.55% | 2.74% | |
| Foreign Portfolio Investors | 19.26% | 18.47% | 17.93% | |
| Financial Institutions/ Banks | 0.04% | 0.1% | ||
| Individual Investors | 16.54% | 17.28% | 16.61% | |
| Others | 21.29% | 21.26% | 22.22% |
Solara Active Pharma Sciences Management
| Name | Designation |
|---|---|
| Mr. Aditya Puri | Chairman |
| Mr. Jitesh Devendra | Managing Director |
| Mr. S Hariharan | Executive Director & CFO |
| Mr. Ankur Nand Thadani | Non Executive Director |
| Mr. Arun Kumar | Non Executive Director |
| Mr. Kartheek Raju | Non Executive Director |
| Mr. Nirmal Bhogilal | Independent Director |
| Mr. R Ramakrishnan | Independent Director |
| Dr. Kausalya Santhanam | Independent Director |
| Ms. Vineeta Rai | Independent Director |
Solara Active Pharma Sciences Forecast
Price Estimates
Solara Active Pharma Sciences FAQs
What is Share Price of Solara Active Pharma Sciences ?
Solara Active Pharma Sciences share price is ₹364 As on 23 March, 2023 | 07:27
What is the Market Cap of Solara Active Pharma Sciences ?
The Market Cap of Solara Active Pharma Sciences is ₹1313.7 Cr As on 23 March, 2023 | 07:27
What is the P/E ratio of Solara Active Pharma Sciences ?
The P/E ratio of Solara Active Pharma Sciences is -54.6 As on 23 March, 2023 | 07:27
What is the PB ratio of Solara Active Pharma Sciences ?
The PB ratio of Solara Active Pharma Sciences is 0.9 As on 23 March, 2023 | 07:27